http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2691620-C1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_764a0ebcface568d4a5b66163ac82423 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-145 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B6-03 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B6-03 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-145 |
filingDate | 2018-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2019-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25990137ceb7646d10498a054a80455f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_405c5f2a4ca93742c7721cdecabb0991 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39a275a5287c8a56f74cf50fda31825c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f806c580e733c5c7c4098de48a63c40 |
publicationDate | 2019-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2691620-C1 |
titleOfInvention | Method for prediction of the risk of developing ischemic heart disease in patients with type 2 diabetes mellitus combined with subclinical thyrotoxicosis |
abstract | FIELD: medicine.SUBSTANCE: invention refers to medicine, namely to cardiology, and can be used in predicting the risk of developing ischemic heart disease (IHD) in patients with type 2 diabetes mellitus combined with subclinical thyrotoxicosis. That is ensured by determining a thyrotropic hormone (TTH) level in the venous blood, calculating an intima media complex (IMC), an E/A ratio, where E is a genotype by e2/e3/e4 polymorphism of the apolipoprotein E gene, and A is a G-308 polymorphism genotype A risk index of developing ischemic heart disease is calculated in patients with type 2 diabetes mellitus with subclinical thyrotoxicosis by original calculation formula. If the IHF probability prediction factor is less than 0.89, a minimum probability of developing IHD in a patient is predicted. If coefficient is 0.90 to 0.99, a high risk of developing IHD is predicted. If the coefficient is more than 1.0, the IHD already exists.EFFECT: method provides accurate prediction of developing risk and primary prevention of ischemic heart disease in this category of patients.1 cl, 4 tbl, 3 ex |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2798065-C1 |
priorityDate | 2018-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 54.